双極性障害治療薬および治療の世界市場レポート 2025年

双極性障害治療薬および治療の市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は6.2％で、104億6,000万米ドルに成長します。予測期間の成長は、双極性障害の世界的な有病率の上昇、メンタルヘルス状態に対する意識の高まり、メンタルヘルス治療の受け入れ拡大、メンタルヘルスケアに対する保険適用範囲の拡大、メンタルヘルスサービスの向上を目指した政府の取り組みなどが背景にあります。この時期の主な動向としては、双極性障害治療薬開発の進展、診断方法・ツールの改善、新剤形の導入、新規治療薬の臨床試験・研究開発の進行、双極性障害治療薬のジェネリック医薬品の利用可能性などが挙げられます。

精神疾患の有病率の増加は、今後数年間の双極性障害治療薬および治療市場の成長を牽引すると予想されます。メンタルヘルス障害とは、人の思考、感情、行動、気分に影響を与える病態であり、多くの場合、日常生活機能と全体的な幸福を阻害します。メンタルヘルス障害の増加は、現代のライフスタイルに起因する慢性的なストレスに起因していると考えられ、仕事、経済、社会的期待に関連する継続的なプレッシャーが感情の健康に悪影響を及ぼし、長期的な心理的課題につながっています。双極性障害治療薬および治療は、気分の変動を安定させ、感情の調節を改善し、これらの障害に関連する破壊的なエピソードの頻度と重症度を減らす上で重要な役割を果たしています。例えば、2024年9月、米国国立精神衛生研究所（NIMH）は、2022年に米国で5,930万人以上の成人が何らかの精神疾患（AMI）に罹患し、成人人口の23.1％を占めたと報告しました。さらに、女性は男性よりもAMIを経験する可能性が高く、女性の26.4％が罹患したのに対し、男性は19.7％でした。精神疾患の増加が続く中、双極性障害治療薬や治療に対する需要は拡大すると思われます。

双極性障害治療薬および治療市場の主なプレーヤーは、安定した長期的治療効果をもたらす徐放性注射製剤などの先進的ソリューションの開発に注力しています。これらの製剤は、時間をかけてゆっくりと薬物を血流に放出するため、毎日の投与の必要性が減り、安定した治療効果が期待できます。例えば、2023年1月、中国の製薬会社であるLuye Pharmaは、成人の統合失調症および双極性Ⅰ型障害の長時間作用型注射治療薬であるRykindo（リスペリドン）のFDA承認を取得しました。この薬剤は、Luye Pharmaが開発した独自のマイクロスフェア技術プラットフォームを利用したもので、2週間ごとに筋肉内注射で投与され、効果が長期間持続します。有効成分であるリスペリドンは、徐放性マイクロスフェア技術を用いて投与されるため、長期間にわたって持続的に放出されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の双極性障害治療薬および治療のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の双極性障害治療薬および治療市場：成長率分析
• 世界の双極性障害治療薬および治療市場の実績：規模と成長、2019～2024年
• 世界の双極性障害治療薬および治療市場の予測：規模と成長、2024～2029年、2034年
• 世界の双極性障害治療薬および治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の双極性障害治療薬および治療市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 気分安定剤
• 抗てんかん薬
• 抗精神病薬
• 抗うつ薬
• 抗不安薬
• 世界の双極性障害治療薬および治療市場：投与経路別、実績と予測、2019～2024年、2024～2029年、2034年
• 経口
• 非経口
• その他
• 世界の双極性障害治療薬および治療市場：双極性障害別、実績と予測、2019～2024年、2024～2029年、2034年
• 双極性I型障害
• 双極性II障害
• 気分循環性障害
• 世界の双極性障害治療薬および治療市場：流通チャネル別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界の双極性障害治療薬および治療市場：気分安定剤のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 炭酸リチウム
• ラモトリギン
• バルプロ酸
• 世界の双極性障害治療薬および治療市場：抗てんかん薬のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• カルバマゼピン
• オキシカルバゼピン
• トピラマート
• 世界の双極性障害治療薬および治療市場：抗精神病薬のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• オランザピン
• リスペリドン
• クエチアピン
• アリピプラゾール
• 世界の双極性障害治療薬および治療市場：抗うつ薬のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 選択的セロトニン再取り込み阻害薬（SSRI）
• セロトニン・ノルアドレナリン再取り込み阻害剤（SNRI）
• 三環系抗うつ薬（TCA）
• 世界の双極性障害治療薬および治療市場：抗不安薬のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ベンゾジアゼピン
• ブスピロン

第7章 地域別・国別分析

• 世界の双極性障害治療薬および治療市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の双極性障害治療薬および治療市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 双極性障害治療薬および治療市場：競合情勢
• 双極性障害治療薬および治療市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Merch & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Sanofi S.A.
• Bristol-Myers Squibb Company
• AstraZeneca PLC
• GSK PLC
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Company
• Teva Pharmaceutical Industries Ltd.
• Boehringer Ingelheim International GmbH
• Otsuka Holdings Co. Ltd.
• Astellas Pharma Inc.
• Sumitomo Pharma America Inc.
• Dr. Reddy's Laboratories Ltd.
• H. Lundbeck A/S
• Cipla Limited
• Gedeon Richter Plc

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 双極性障害治療薬および治療市場2029年：新たな機会を提供する国
• 双極性障害治療薬および治療市場2029年：新たな機会を提供するセグメント
• 双極性障害治療薬および治療市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Bipolar disorder drugs and treatments involve a comprehensive approach aimed at managing significant mood swings and promoting long-term mental stability. This approach focuses on regulating brain function to reduce the severity and frequency of mood episodes, while also addressing related issues such as disrupted sleep, anxiety, and difficulties with concentration.

The primary treatments for bipolar disorder include mood stabilizers, anticonvulsants, antipsychotic drugs, antidepressants, and anti-anxiety medications. Mood stabilizers are designed to help maintain a stable mood, preventing the extreme highs (mania) and lows (depression) associated with bipolar disorder. These drugs can be administered through various methods, including oral, parenteral, and other routes, and are used to treat bipolar I disorder, bipolar II disorder, and cyclothymic disorder. They are available through multiple distribution channels such as hospital pharmacies, retail pharmacies, and online pharmacies.

The bipolar disorder drugs and treatment market research report is one of a series of new reports from The Business Research Company that provides bipolar disorder drugs and treatment market statistics, including bipolar disorder drugs and treatment industry global market size, regional shares, competitors with a bipolar disorder drugs and treatment market share, detailed bipolar disorder drugs and treatment market segments, market trends and opportunities, and any further data you may need to thrive in the bipolar disorder drugs and treatment industry. This bipolar disorder drugs and treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bipolar disorder drugs and treatment market size has grown strongly in recent years. It will grow from $7.74 billion in 2024 to $8.24 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth observed in the historical period can be attributed to factors such as rising healthcare expenditures, increased research and funding for mental health, a growing number of healthcare professionals specializing in mental health, more early diagnoses of bipolar disorder, and an increasing demand for outpatient psychiatric care.

The bipolar disorder drugs and treatment market size is expected to see strong growth in the next few years. It will grow to $10.46 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The projected growth in the forecast period is driven by the rising global prevalence of bipolar disorder, greater awareness of mental health conditions, increasing acceptance of mental health treatment, broader insurance coverage for mental health care, and government initiatives aimed at improving mental health services. Key trends during this period include advancements in bipolar disorder drug development, improvements in diagnostic methods and tools, the introduction of new drug formulations, ongoing clinical trials and research on novel medications, and the availability of generic drugs for bipolar disorder.

The increasing prevalence of mental health disorders is expected to drive the growth of the bipolar disorder drugs and treatment market in the coming years. Mental health disorders are conditions that impact a person's thoughts, feelings, behavior, or mood, often hindering daily functioning and overall well-being. The rise in mental health disorders can be attributed to chronic stress stemming from modern lifestyles, with ongoing pressures related to work, finances, and social expectations negatively affecting emotional health and leading to long-term psychological challenges. Bipolar disorder drugs and treatments play a vital role in stabilizing mood fluctuations, improving emotional regulation, and reducing the frequency and severity of disruptive episodes associated with these disorders. For example, in September 2024, the National Institute of Mental Health (NIMH) reported that over 59.3 million adults in the US were affected by any mental illness (AMI) in 2022, which accounted for 23.1% of the adult population. Additionally, women were more likely than men to experience AMI, with 26.4% of women affected compared to 19.7% of men. As mental health disorders continue to rise, the demand for bipolar disorder drugs and treatments will grow.

Key players in the bipolar disorder drugs and treatment market are focusing on the development of advanced solutions such as extended-release injectable formulations, which offer consistent and long-term therapeutic effects. These formulations slowly release medication into the bloodstream over time, reducing the need for daily doses and ensuring stable therapeutic outcomes. For example, in January 2023, Luye Pharma, a China-based pharmaceutical company, received FDA approval for Rykindo (risperidone), a long-acting injectable treatment for adult schizophrenia and bipolar I disorder. This drug, which utilizes a unique microsphere technology platform developed by Luye Pharma, is administered via an intramuscular injection every two weeks, providing long-lasting effects. The active ingredient, risperidone, is delivered using the extended-release microsphere technology to ensure sustained release over time.

In April 2025, Johnson & Johnson, a US-based healthcare company, acquired Intra-Cellular Therapies Inc. for an undisclosed amount. This acquisition expands Johnson & Johnson's portfolio, adding CAPLYTA (lumateperone), a once-daily oral therapy approved for the treatment of schizophrenia and the first FDA-approved treatment for bipolar depression. The acquisition also includes ITI-1284, a promising Phase 2 compound being investigated for generalized anxiety disorder (GAD) and Alzheimer's disease-related psychosis and agitation. This deal strengthens Johnson & Johnson's clinical pipeline and supports its strategic focus on mental health and related therapeutic areas. Intra-Cellular Therapies Inc. is a US-based provider of bipolar disorder drugs and treatments.

Major players in the bipolar disorder drugs and treatment market are Pfizer Inc., Johnson & Johnson, Merch & Co. Inc., AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, GSK PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Otsuka Holdings Co. Ltd., Astellas Pharma Inc., Sumitomo Pharma America Inc., Dr. Reddy's Laboratories Ltd., H. Lundbeck A/S, Cipla Limited, Gedeon Richter Plc, Lupin Limited, Neurocrine Biosciences Inc., and Alkermes Plc.

North America was the largest region in the bipolar disorder drugs and treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in bipolar disorder drugs and treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the bipolar disorder drugs and treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bipolar disorder drugs and treatment market consists of revenues earned by entities by providing services such as research and development, medical consultation services, mental health counseling support, and telehealth services. The market value includes the value of related goods sold by the service provider or included within the service offering. The bipolar disorder drugs and treatment market also includes sales of wearable monitoring devices, home diagnostic kits, cognitive assessment devices, and neurostimulation devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bipolar Disorder Drugs And Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bipolar disorder drugs and treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bipolar disorder drugs and treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bipolar disorder drugs and treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Types: Mood Stabilizers; Anticonvulsants; Antipsychotic Drugs; Antidepressant Drugs; Anti-Anxiety Drugs
• 2) By Route Of Administration: Oral; Parenteral; Other Routes Of Administration
• 3) By Bipolar Disorder: Bipolar I Disorder; Bipolar II Disorder; Cyclothymic Disorder
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• Subsegments:
• 1) By Mood Stabilizers: Lithium Carbonate; Lamotrigine; Valproate
• 2) By Anticonvulsants: Carbamazepine; Oxcarbazepine; Topiramate
• 3) By Antipsychotic Drugs: Olanzapine; Risperidone; Quetiapine; Aripiprazole
• 4) By Antidepressant Drugs: Selective Serotonin Reuptake Inhibitors (SSRIs); Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs); Tricyclic Antidepressants (TCAs)
• 5) By Anti-Anxiety Drugs: Benzodiazepines; Buspirone
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merch & Co. Inc.; AbbVie Inc.; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Bipolar Disorder Drugs And Treatment Market Characteristics

3. Bipolar Disorder Drugs And Treatment Market Trends And Strategies

4. Bipolar Disorder Drugs And Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Bipolar Disorder Drugs And Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Bipolar Disorder Drugs And Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Bipolar Disorder Drugs And Treatment Market Growth Rate Analysis
• 5.4. Global Bipolar Disorder Drugs And Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Bipolar Disorder Drugs And Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Bipolar Disorder Drugs And Treatment Total Addressable Market (TAM)

6. Bipolar Disorder Drugs And Treatment Market Segmentation

• 6.1. Global Bipolar Disorder Drugs And Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mood Stabilizers
• Anticonvulsants
• Antipsychotic Drugs
• Antidepressant Drugs
• Anti-Anxiety Drugs
• 6.2. Global Bipolar Disorder Drugs And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Parenteral
• Other Routes Of Administration
• 6.3. Global Bipolar Disorder Drugs And Treatment Market, Segmentation By Bipolar Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bipolar I Disorder
• Bipolar II Disorder
• Cyclothymic Disorder
• 6.4. Global Bipolar Disorder Drugs And Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.5. Global Bipolar Disorder Drugs And Treatment Market, Sub-Segmentation Of Mood Stabilizers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lithium Carbonate
• Lamotrigine
• Valproate
• 6.6. Global Bipolar Disorder Drugs And Treatment Market, Sub-Segmentation Of Anticonvulsants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Carbamazepine
• Oxcarbazepine
• Topiramate
• 6.7. Global Bipolar Disorder Drugs And Treatment Market, Sub-Segmentation Of Antipsychotic Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Olanzapine
• Risperidone
• Quetiapine
• Aripiprazole
• 6.8. Global Bipolar Disorder Drugs And Treatment Market, Sub-Segmentation Of Antidepressant Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Selective Serotonin Reuptake Inhibitors (SSRIs)
• Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
• Tricyclic Antidepressants (TCAs)
• 6.9. Global Bipolar Disorder Drugs And Treatment Market, Sub-Segmentation Of Anti-Anxiety Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Benzodiazepines
• Buspirone

7. Bipolar Disorder Drugs And Treatment Market Regional And Country Analysis

• 7.1. Global Bipolar Disorder Drugs And Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Bipolar Disorder Drugs And Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Bipolar Disorder Drugs And Treatment Market

• 8.1. Asia-Pacific Bipolar Disorder Drugs And Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Bipolar Disorder Drugs And Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Bipolar Disorder Drugs And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Bipolar Disorder Drugs And Treatment Market, Segmentation By Bipolar Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Bipolar Disorder Drugs And Treatment Market

• 9.1. China Bipolar Disorder Drugs And Treatment Market Overview
• 9.2. China Bipolar Disorder Drugs And Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Bipolar Disorder Drugs And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Bipolar Disorder Drugs And Treatment Market, Segmentation By Bipolar Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Bipolar Disorder Drugs And Treatment Market

• 10.1. India Bipolar Disorder Drugs And Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Bipolar Disorder Drugs And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Bipolar Disorder Drugs And Treatment Market, Segmentation By Bipolar Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Bipolar Disorder Drugs And Treatment Market

• 11.1. Japan Bipolar Disorder Drugs And Treatment Market Overview
• 11.2. Japan Bipolar Disorder Drugs And Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Bipolar Disorder Drugs And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Bipolar Disorder Drugs And Treatment Market, Segmentation By Bipolar Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Bipolar Disorder Drugs And Treatment Market

• 12.1. Australia Bipolar Disorder Drugs And Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Bipolar Disorder Drugs And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Bipolar Disorder Drugs And Treatment Market, Segmentation By Bipolar Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Bipolar Disorder Drugs And Treatment Market

• 13.1. Indonesia Bipolar Disorder Drugs And Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Bipolar Disorder Drugs And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Bipolar Disorder Drugs And Treatment Market, Segmentation By Bipolar Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Bipolar Disorder Drugs And Treatment Market

• 14.1. South Korea Bipolar Disorder Drugs And Treatment Market Overview
• 14.2. South Korea Bipolar Disorder Drugs And Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Bipolar Disorder Drugs And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Bipolar Disorder Drugs And Treatment Market, Segmentation By Bipolar Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Bipolar Disorder Drugs And Treatment Market

• 15.1. Western Europe Bipolar Disorder Drugs And Treatment Market Overview
• 15.2. Western Europe Bipolar Disorder Drugs And Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Bipolar Disorder Drugs And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Bipolar Disorder Drugs And Treatment Market, Segmentation By Bipolar Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Bipolar Disorder Drugs And Treatment Market

• 16.1. UK Bipolar Disorder Drugs And Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Bipolar Disorder Drugs And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Bipolar Disorder Drugs And Treatment Market, Segmentation By Bipolar Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Bipolar Disorder Drugs And Treatment Market

• 17.1. Germany Bipolar Disorder Drugs And Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Bipolar Disorder Drugs And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Bipolar Disorder Drugs And Treatment Market, Segmentation By Bipolar Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Bipolar Disorder Drugs And Treatment Market

• 18.1. France Bipolar Disorder Drugs And Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Bipolar Disorder Drugs And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Bipolar Disorder Drugs And Treatment Market, Segmentation By Bipolar Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Bipolar Disorder Drugs And Treatment Market

• 19.1. Italy Bipolar Disorder Drugs And Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Bipolar Disorder Drugs And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Bipolar Disorder Drugs And Treatment Market, Segmentation By Bipolar Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Bipolar Disorder Drugs And Treatment Market

• 20.1. Spain Bipolar Disorder Drugs And Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Bipolar Disorder Drugs And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Bipolar Disorder Drugs And Treatment Market, Segmentation By Bipolar Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Bipolar Disorder Drugs And Treatment Market

• 21.1. Eastern Europe Bipolar Disorder Drugs And Treatment Market Overview
• 21.2. Eastern Europe Bipolar Disorder Drugs And Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Bipolar Disorder Drugs And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Bipolar Disorder Drugs And Treatment Market, Segmentation By Bipolar Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Bipolar Disorder Drugs And Treatment Market

• 22.1. Russia Bipolar Disorder Drugs And Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Bipolar Disorder Drugs And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Bipolar Disorder Drugs And Treatment Market, Segmentation By Bipolar Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Bipolar Disorder Drugs And Treatment Market

• 23.1. North America Bipolar Disorder Drugs And Treatment Market Overview
• 23.2. North America Bipolar Disorder Drugs And Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Bipolar Disorder Drugs And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Bipolar Disorder Drugs And Treatment Market, Segmentation By Bipolar Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Bipolar Disorder Drugs And Treatment Market

• 24.1. USA Bipolar Disorder Drugs And Treatment Market Overview
• 24.2. USA Bipolar Disorder Drugs And Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Bipolar Disorder Drugs And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Bipolar Disorder Drugs And Treatment Market, Segmentation By Bipolar Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Bipolar Disorder Drugs And Treatment Market

• 25.1. Canada Bipolar Disorder Drugs And Treatment Market Overview
• 25.2. Canada Bipolar Disorder Drugs And Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Bipolar Disorder Drugs And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Bipolar Disorder Drugs And Treatment Market, Segmentation By Bipolar Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Bipolar Disorder Drugs And Treatment Market

• 26.1. South America Bipolar Disorder Drugs And Treatment Market Overview
• 26.2. South America Bipolar Disorder Drugs And Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Bipolar Disorder Drugs And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Bipolar Disorder Drugs And Treatment Market, Segmentation By Bipolar Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Bipolar Disorder Drugs And Treatment Market

• 27.1. Brazil Bipolar Disorder Drugs And Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Bipolar Disorder Drugs And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Bipolar Disorder Drugs And Treatment Market, Segmentation By Bipolar Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Bipolar Disorder Drugs And Treatment Market

• 28.1. Middle East Bipolar Disorder Drugs And Treatment Market Overview
• 28.2. Middle East Bipolar Disorder Drugs And Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Bipolar Disorder Drugs And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Bipolar Disorder Drugs And Treatment Market, Segmentation By Bipolar Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Bipolar Disorder Drugs And Treatment Market

• 29.1. Africa Bipolar Disorder Drugs And Treatment Market Overview
• 29.2. Africa Bipolar Disorder Drugs And Treatment Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Bipolar Disorder Drugs And Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Bipolar Disorder Drugs And Treatment Market, Segmentation By Bipolar Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Bipolar Disorder Drugs And Treatment Market Competitive Landscape And Company Profiles

• 30.1. Bipolar Disorder Drugs And Treatment Market Competitive Landscape
• 30.2. Bipolar Disorder Drugs And Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merch & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Bipolar Disorder Drugs And Treatment Market Other Major And Innovative Companies

• 31.1. Sanofi S.A.
• 31.2. Bristol-Myers Squibb Company
• 31.3. AstraZeneca PLC
• 31.4. GSK PLC
• 31.5. Takeda Pharmaceutical Company Limited
• 31.6. Eli Lilly and Company
• 31.7. Teva Pharmaceutical Industries Ltd.
• 31.8. Boehringer Ingelheim International GmbH
• 31.9. Otsuka Holdings Co. Ltd.
• 31.10. Astellas Pharma Inc.
• 31.11. Sumitomo Pharma America Inc.
• 31.12. Dr. Reddy's Laboratories Ltd.
• 31.13. H. Lundbeck A/S
• 31.14. Cipla Limited
• 31.15. Gedeon Richter Plc

32. Global Bipolar Disorder Drugs And Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bipolar Disorder Drugs And Treatment Market

34. Recent Developments In The Bipolar Disorder Drugs And Treatment Market

35. Bipolar Disorder Drugs And Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Bipolar Disorder Drugs And Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Bipolar Disorder Drugs And Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Bipolar Disorder Drugs And Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer